Acute L-glutamine deprivation compromises VEGF-A upregulation in A549/8 human carcinoma cells

Journal of Cellular Physiology

Volumn 212, Issue 2, 2007, Pages 463-472

  Drogat, Benjamin ^a   Bouchecareilh, Marion ^a   North, Sophie ^a   Petibois, Cyril ^b   Déléris, Gérard ^b   Chevet, Eric ^a,c   Bikfalvi, Andréas ^a   Moenner, Michel ^a  

^a INSERM   (France)

^b CNRS   (France)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; VASCULOTROPIN A;

AMINO ACID METABOLISM; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL DEATH; CELL HYPOXIA; CONTROLLED STUDY; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HYPOGLYCEMIA; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR VASCULARIZATION;

AMINO ACIDS, ESSENTIAL; APOPTOSIS; CELL CYCLE; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; EUKARYOTIC INITIATION FACTOR-2; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLUTAMINE; HUMANS; LUNG NEOPLASMS; NECROSIS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34347389910     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21044     Document Type: Article

References (61)

1. Abcouwer SF, Schwarz C, Meguid RA. 1999. Glutamine deprivation induces the expression of GADD45 and GADD153 primarily by mRNA stabilization. J Biol Chem 274:28645-28651.
2. Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL. 2002. Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Invest Ophthalmol Vis Sci 43:2791-2798.
3. Barnes D, Sato G. 1980. Serum-free cell culture: A unifying approach. Cell 22:649-655.
4. Bouzier AK, Quesson B, Valeins H, Canioni P, Merle M. 1999. [1-{13)C]glucose metabolism in the tumoral and nontumoral cerebral tissue of aglioma-bearing rat. J Neurochem 72:2445-2455.
5. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 271:21793-21797.
6. Brewer JW, Hendershot LM, Sherr CJ, Diehl JA. 1999. Mammalian unfolded protein response inhibits cyclin DI translation and cell-cycle progression. Proc Natl Acad Sci USA 96:8505-8510.
7. Brody T. 1994. Nutritional biochemistry. San Diego: Academic Press, Inc. pp 295-354.
8. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC, Corless M, Newsholme P. 2005. Molecular mechanisms of glutamine action. J Cell Physiol 204:392-401.
9. Dang CV, Semenza GL. 1999. Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72.
10. De Giorgi F, Lartigue L, Ichas F. 2000. Electrical coupling and plasticity of the mitochondrial network. Cell Calcium 28:365-370.
11. Deleris G, Petibois C. 2003. Applications of FT-IR spectrometry to plasma contents analysis and monitoring. Vib Spectrosc 32:129-136.
12. Esumi H, Izuishi K, Kato K, Hashimoto K, Kurashima Y, Kishimoto A, Ogura T, Ozawa T. 2002. Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5′-AMP-activated protein kinase-dependent manner. J Biol Chem 277:32791-32798.
13. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
14. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6:1099-1108.
15. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, Ron D. 2003. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11:619-633.
16. Heiskanen KM, Bhat MB, Wang H-W, Ma J, Nieminen A-L. 1999. Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J Biol Chem 274:5654-5658.
17. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. 2002. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res 8:1284-1291.
18. Houlgatte R, Wion D, Brachet P. 1989. Levels of nerve growth factor secreted by rat primary fibroblasts and iris transplants are influenced by serum and glucocorticoids. Dev Brain Res 47:171-179.
19. Jiang BH, Agani F, Passaniti A, Semenza GL. 1997. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression. Cancer Res 57:5328-5335.
20. Jousse C, Bruhat A, Harding HP, Ferrara M, Ron D, Fafournoux P. 1999. Amino acid limitation regulates CHOP expression through a specific pathway independent of the unfolded protein response. FEBS Lett 448:211-216.
21. Kaufman RJ, Scheuner D, Schroder M, Shen X, Lee K, Liu CY, Arnold SM. 2002. The unfolded protein response in nutrient sensing and differentiation. Nat Rev Mol Cell Biol 3:411-421.
22. Kotch LE, Iyer NV, Laughner E, Semenza GL. 1999. Defective vascularization of HIF-1 alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209:254-267.
23. Kovacevic Z, Morris HP. 1972. The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res 32:326-333.
24. Kovacevic Z, Jerance D, Brkljac O. 1988. The role of glutamine oxidation and the purine nucleotide cycle for adaptation of tumour energetics to the transition from the anaerobic to the aerobic state. Biochem J 252:381-386.
25. Kwon SJ, Lee YJ. 2005. Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin Cancer Res 11:4694-4700.
26. Lazo PA. 1981. Amino acids and glucose utilization by different metabolic pathways in ascites-tumour cells. Eur J Biochem 117:19-25.
27. Le NT, Richardson DR. 2002. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603:31-46.
28. Lee AH, Iwakoshi NN, Glimcher LH. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 23:7448-7459.
29. Lobo C, Ruiz-Bellido MA, Aledo JC, Marquez J, Nunez De Castro I, Alonso FJ. 2000. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem J 348:257-261.
30. Loo DT, Fuquay JI, Rawson CL, Barnes DW. 1987. Extended culture of mouse embryo cells without senescence: Inhibition by serum. Science 236:200-202.
31. Lu J, Kunimoto S, Yamazaki Y, Kaminishi M, Esumi H, Esumi H. 2004. Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Sci 95:547-552.
32. Ma Y, Hendershot LM. 2004a. Herp is dually regulated by both the endoplasmic reticulum stress-specific branch of the unfolded protein response and a branch that is shared with other cellular stress pathways. J Biol Chem 279:13792-13799.
33. Ma Y, Hendershot LM. 2004b. The role of the unfolded protein response in tumour development: Friend of foe ? Nat Rev Cancer 4:966-977.
34. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403-407.
35. Mates JM, Perez-Gomez C, Nunez de Cartro I, Asenjo M, Marquez J. 2002. Glutamine and its relationship with intracellular redox status, oxidative stress and proliferation/death. Int J Biochem C Biol 34:439-458.
36. McKeehan WL. 1982. Glycolysis, glutaminolysis and cell proliferation. Cell Biol Int Rep 6:635-650.
37. Medina MA. 2001. Glutamine and cancer. J Nutr 131:2539S-2542S.
38. Milanini J, Vinals F, Pouyssegur J, Pages G. 1998. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273:18165-18172.
39. Moenner M, Hatzi E, Badet J. 1997. Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions. In Vitro Cell Dev Biol Anim 33:553-561.
40. Petibois C, Melin AM, Perromat A, Cazorla G, Deleris G. 2000. Glucose and lactate concentration determination on single microsamples by Fourier-transform infrared spectroscopy. J Lab Clin Med 135:210-215.
41. Petibois C, Gionnet K, Goncalves M, Perromat A, Moenner M, Deleris G. 2006. Analytical performances of FT-IR spectrometry and imaging for concentration measurements within biological fluids, cells, and tissues. Analyst 131:640-647.
42. Pugh CW, Ratcliffe PJ. 2003. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 9:677-684.
43. Qiu H, Hu C, Dong J, Hinnebusch AG. 2002. Mutations that bypass tRNA binding activate the intrinsically defective kinase domain in G CN2. Genes Dev 16:1271-1280.
44. Rak J, Yu JL. 2004. Oncogenes and tumor angiogenesis: The question of vascular "supply" and vascular "demand". Semin Cancer Biol 14:93-104.
45. Ratcliffe PJ, Pugh CW, Maxwell PH. 2000. Targeting tumors through the HIF system. Nat Med 6:1315-1316.
46. Reitzer LJ, Wice BM, Kennell D. 1979. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 254:2669-2676.
47. Richard DE, Berra E, Pouyssegur J. 2000. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275:26765-26771.
48. Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF. 2004. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor A TF4. J Biol Chem 279:14844-14852.
49. Roybal CN, Hunsaker LA, Barbash O, Vander Jagt DL, Abcouwer SF. 2005. The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism. J Biol Chem 280:20331-20339.
50. Sage H. 1986. Culture shock. Selective uptake and rapid release of a novel serum protein by endothelial cells in vitro. J Biol Chem 261:7082-7092.
51. Sebolt JS, Weber G. 1984. Negative correlation of L-glutamine concentration with proliferation rate in rat hepatomas. Life Sci 34:301-306.
52. Semenza GL. 2003. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
53. Shweiki D, Neeman M, Itin A, Keshet E. 1995. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 92:768-772.
54. Souba WW. 1993. Glutamine and cancer. Ann Surg 218:715-728.
55. Vaupel P, Hockel M. 2000. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance. Int J Oncol 17:869-879.
56. Vaupel P, Kallinowski F, Okunieff P. 1989. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49:6449-6465.
57. Yoshida H, Haze K, Yanagi H, Yura T, Mori K. 1998. Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem 273:33741-33749.
58. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-891.
59. Yoshida H, Matsui T, Hosokawa N, Kaufman RJ, Nagata K, Mori K. 2003. A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 4:265-271.
60. Yun H, Lee M, Kim SS, Ha J. 2005. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem 280:9963-9972.
61. Zhu C, Johansen FE, Prywes R. 1997. Interaction of ATF6 and serum response factor. Mol Cell Biol 17:4957-4966.